Clinical Trial Results

Showing: All studies [change]
Condition: Diabetes Location: Mesa, Arizona 25 trials found
New Search
Filter
Trial Phase
Study Type
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
PHASE3INTERVENTIONAL Dothan, Alabama +4 more
RECRUITING
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
PHASE3INTERVENTIONAL Fairhope, Alabama +4 more
RECRUITING
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
PHASE2INTERVENTIONAL Mesa, Arizona +4 more
RECRUITING
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems
NAINTERVENTIONAL Mesa, Arizona +4 more
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
WatchWell: Simple and Practical Strategies to Reduce the Negative Health Impact of Sedentary Screen Time
NAINTERVENTIONAL Tempe, Arizona
RECRUITING
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
The RESET System Pivotal Clinical Trial (Protocol Revision K)
NAINTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
NAINTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
PHASE2INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects
PHASE1INTERVENTIONAL Chandler, Arizona +2 more
RECRUITING
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
PHASE2INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NAINTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity
PHASE2INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Gastroparesis Registry 4
N/AOBSERVATIONAL Scottsdale, Arizona +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
NAINTERVENTIONAL Phoenix, Arizona +1 more
RECRUITING
Filter Trials
Trial Phase
Study Type